Ractopamine residue in meat might protect people from Parkinson disease
Author:
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 145, 110397
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- β2‐adrenoceptor agonists and antagonists and risk of Parkinson's diseaseMovement Disorders, 2018
- The Case for TAAR1 as a Modulator of Central Nervous System FunctionFrontiers in Pharmacology, 2018
- Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking PalsyMovement Disorders, 2017
- β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s diseaseScience, 2017
- The epidemiology of Parkinson's disease: risk factors and preventionThe Lancet Neurology, 2016
- An update on the diagnosis and treatment of Parkinson diseaseCanadian Medical Association Journal, 2016
- Epidemiology of Parkinson's diseaseRevue Neurologique, 2016
- Ractopamine, a Livestock Feed Additive, Is a Full Agonist at Trace Amine–Associated Receptor 1The Journal of Pharmacology and Experimental Therapeutics, 2014
- Ractopamine as a metabolic modifier feed additive for finishing pigs: a reviewBrazilian Archives of Biology and Technology, 2012
- The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic systemProceedings of the National Academy of Sciences, 2009